These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 32469608)

  • 1. Corrected QT Interval-Polygenic Risk Score and Its Contribution to Type 1, Type 2, and Type 3 Long-QT Syndrome in Probands and Genotype-Positive Family Members.
    Turkowski KL; Dotzler SM; Tester DJ; Giudicessi JR; Bos JM; Speziale AD; Vollenweider JM; Ackerman MJ
    Circ Genom Precis Med; 2020 Aug; 13(4):e002922. PubMed ID: 32469608
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epinephrine-induced QT interval prolongation: a gene-specific paradoxical response in congenital long QT syndrome.
    Ackerman MJ; Khositseth A; Tester DJ; Hejlik JB; Shen WK; Porter CB
    Mayo Clin Proc; 2002 May; 77(5):413-21. PubMed ID: 12004990
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transethnic Genome-Wide Association Study Provides Insights in the Genetic Architecture and Heritability of Long QT Syndrome.
    Lahrouchi N; Tadros R; Crotti L; Mizusawa Y; Postema PG; Beekman L; Walsh R; Hasegawa K; Barc J; Ernsting M; Turkowski KL; Mazzanti A; Beckmann BM; Shimamoto K; Diamant UB; Wijeyeratne YD; Kucho Y; Robyns T; Ishikawa T; Arbelo E; Christiansen M; Winbo A; Jabbari R; Lubitz SA; Steinfurt J; Rudic B; Loeys B; Shoemaker MB; Weeke PE; Pfeiffer R; Davies B; Andorin A; Hofman N; Dagradi F; Pedrazzini M; Tester DJ; Bos JM; Sarquella-Brugada G; Campuzano Ó; Platonov PG; Stallmeyer B; Zumhagen S; Nannenberg EA; Veldink JH; van den Berg LH; Al-Chalabi A; Shaw CE; Shaw PJ; Morrison KE; Andersen PM; Müller-Nurasyid M; Cusi D; Barlassina C; Galan P; Lathrop M; Munter M; Werge T; Ribasés M; Aung T; Khor CC; Ozaki M; Lichtner P; Meitinger T; van Tintelen JP; Hoedemaekers Y; Denjoy I; Leenhardt A; Napolitano C; Shimizu W; Schott JJ; Gourraud JB; Makiyama T; Ohno S; Itoh H; Krahn AD; Antzelevitch C; Roden DM; Saenen J; Borggrefe M; Odening KE; Ellinor PT; Tfelt-Hansen J; Skinner JR; van den Berg MP; Olesen MS; Brugada J; Brugada R; Makita N; Breckpot J; Yoshinaga M; Behr ER; Rydberg A; Aiba T; Kääb S; Priori SG; Guicheney P; Tan HL; Newton-Cheh C; Ackerman MJ; Schwartz PJ; Schulze-Bahr E; Probst V; Horie M; Wilde AA; Tanck MWT; Bezzina CR
    Circulation; 2020 Jul; 142(4):324-338. PubMed ID: 32429735
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk for life-threatening cardiac events in patients with genotype-confirmed long-QT syndrome and normal-range corrected QT intervals.
    Goldenberg I; Horr S; Moss AJ; Lopes CM; Barsheshet A; McNitt S; Zareba W; Andrews ML; Robinson JL; Locati EH; Ackerman MJ; Benhorin J; Kaufman ES; Napolitano C; Platonov PG; Priori SG; Qi M; Schwartz PJ; Shimizu W; Towbin JA; Vincent GM; Wilde AA; Zhang L
    J Am Coll Cardiol; 2011 Jan; 57(1):51-9. PubMed ID: 21185501
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Single nucleotide polymorphisms in arrhythmia genes modify the risk of cardiac events and sudden death in long QT syndrome.
    Earle N; Yeo Han D; Pilbrow A; Crawford J; Smith W; Shelling AN; Cameron V; Love DR; Skinner JR
    Heart Rhythm; 2014 Jan; 11(1):76-82. PubMed ID: 24096169
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of Artificial Intelligence and Deep Neural Networks in Evaluation of Patients With Electrocardiographically Concealed Long QT Syndrome From the Surface 12-Lead Electrocardiogram.
    Bos JM; Attia ZI; Albert DE; Noseworthy PA; Friedman PA; Ackerman MJ
    JAMA Cardiol; 2021 May; 6(5):532-538. PubMed ID: 33566059
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical aspects of the three major genetic forms of long QT syndrome (LQT1, LQT2, LQT3).
    Kutyifa V; Daimee UA; McNitt S; Polonsky B; Lowenstein C; Cutter K; Lopes C; Zareba W; Moss AJ
    Ann Noninvasive Electrocardiol; 2018 May; 23(3):e12537. PubMed ID: 29504689
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of Genetic and Clinical Aspects of Congenital Long QT Syndrome With Life-Threatening Arrhythmias in Japanese Patients.
    Shimizu W; Makimoto H; Yamagata K; Kamakura T; Wada M; Miyamoto K; Inoue-Yamada Y; Okamura H; Ishibashi K; Noda T; Nagase S; Miyazaki A; Sakaguchi H; Shiraishi I; Makiyama T; Ohno S; Itoh H; Watanabe H; Hayashi K; Yamagishi M; Morita H; Yoshinaga M; Aizawa Y; Kusano K; Miyamoto Y; Kamakura S; Yasuda S; Ogawa H; Tanaka T; Sumitomo N; Hagiwara N; Fukuda K; Ogawa S; Aizawa Y; Makita N; Ohe T; Horie M; Aiba T
    JAMA Cardiol; 2019 Mar; 4(3):246-254. PubMed ID: 30758498
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Utility of the recovery electrocardiogram after exercise: a novel indicator for the diagnosis and genotyping of long QT syndrome?
    Chattha IS; Sy RW; Yee R; Gula LJ; Skanes AC; Klein GJ; Bennett MT; Krahn AD
    Heart Rhythm; 2010 Jul; 7(7):906-11. PubMed ID: 20226272
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Utility of treadmill testing in identification and genotype prediction in long-QT syndrome.
    Wong JA; Gula LJ; Klein GJ; Yee R; Skanes AC; Krahn AD
    Circ Arrhythm Electrophysiol; 2010 Apr; 3(2):120-5. PubMed ID: 20071715
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gene-specific effect of beta-adrenergic blockade on corrected QT interval in the long QT syndrome.
    Extramiana F; Maison-Blanche P; Denjoy I; De Jode P; Messali A; Labbé JP; Leenhardt A
    Ann Noninvasive Electrocardiol; 2013 Jul; 18(4):399-408. PubMed ID: 23879280
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gene-specific response of dynamic ventricular repolarization to sympathetic stimulation in LQT1, LQT2 and LQT3 forms of congenital long QT syndrome.
    Noda T; Takaki H; Kurita T; Suyama K; Nagaya N; Taguchi A; Aihara N; Kamakura S; Sunagawa K; Nakamura K; Ohe T; Horie M; Napolitano C; Towbin JA; Priori SG; Shimizu W
    Eur Heart J; 2002 Jun; 23(12):975-83. PubMed ID: 12069453
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiac Mechanical Alterations and Genotype Specific Differences in Subjects With Long QT Syndrome.
    Leren IS; Hasselberg NE; Saberniak J; Håland TF; Kongsgård E; Smiseth OA; Edvardsen T; Haugaa KH
    JACC Cardiovasc Imaging; 2015 May; 8(5):501-510. PubMed ID: 25890583
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Determination and Interpretation of the QT Interval.
    Vink AS; Neumann B; Lieve KVV; Sinner MF; Hofman N; El Kadi S; Schoenmaker MHA; Slaghekke HMJ; de Jong JSSG; Clur SB; Blom NA; Kääb S; Wilde AAM; Postema PG
    Circulation; 2018 Nov; 138(21):2345-2358. PubMed ID: 30571576
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic value of epinephrine test for genotyping LQT1, LQT2, and LQT3 forms of congenital long QT syndrome.
    Shimizu W; Noda T; Takaki H; Nagaya N; Satomi K; Kurita T; Suyama K; Aihara N; Sunagawa K; Echigo S; Miyamoto Y; Yoshimasa Y; Nakamura K; Ohe T; Towbin JA; Priori SG; Kamakura S
    Heart Rhythm; 2004 Sep; 1(3):276-83. PubMed ID: 15851169
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Derivation and validation of a simple exercise-based algorithm for prediction of genetic testing in relatives of LQTS probands.
    Sy RW; van der Werf C; Chattha IS; Chockalingam P; Adler A; Healey JS; Perrin M; Gollob MH; Skanes AC; Yee R; Gula LJ; Leong-Sit P; Viskin S; Klein GJ; Wilde AA; Krahn AD
    Circulation; 2011 Nov; 124(20):2187-94. PubMed ID: 22042885
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monogenic and Polygenic Contributions to QTc Prolongation in the Population.
    Nauffal V; Morrill VN; Jurgens SJ; Choi SH; Hall AW; Weng LC; Halford JL; Austin-Tse C; Haggerty CM; Harris SL; Wong EK; Alonso A; Arking DE; Benjamin EJ; Boerwinkle E; Min YI; Correa A; Fornwalt BK; Heckbert SR; ; Kooperberg C; Lin HJ; J F Loos R; Rice KM; Gupta N; Blackwell TW; Mitchell BD; Morrison AC; Psaty BM; Post WS; Redline S; Rehm HL; Rich SS; Rotter JI; Soliman EZ; Sotoodehnia N; Lunetta KL; Ellinor PT; Lubitz SA;
    Circulation; 2022 May; 145(20):1524-1533. PubMed ID: 35389749
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genotype-Specific ECG-Based Risk Stratification Approaches in Patients With Long-QT Syndrome.
    Rieder M; Kreifels P; Stuplich J; Ziupa D; Servatius H; Nicolai L; Castiglione A; Zweier C; Asatryan B; Odening KE
    Front Cardiovasc Med; 2022; 9():916036. PubMed ID: 35911527
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostic value of T-wave morphology changes during "QT stretching" in patients with long QT syndrome.
    Chorin E; Havakuk O; Adler A; Steinvil A; Rozovski U; van der Werf C; Postema PG; Topaz G; Wilde AA; Viskin S; Rosso R
    Heart Rhythm; 2015 Nov; 12(11):2263-71. PubMed ID: 26142298
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis for Genetic Modifiers of Disease Severity in Patients With Long-QT Syndrome Type 2.
    Kolder ICRM; Tanck MWT; Postema PG; Barc J; Sinner MF; Zumhagen S; Husemann A; Stallmeyer B; Koopmann TT; Hofman N; Pfeufer A; Lichtner P; Meitinger T; Beckmann BM; Myerburg RJ; Bishopric NH; Roden DM; Kääb S; Wilde AAM; Schott JJ; Schulze-Bahr E; Bezzina CR
    Circ Cardiovasc Genet; 2015 Jun; 8(3):447-456. PubMed ID: 25737393
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.